Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
Lieber Institute awarded $1 million grant to foster racial diversity across neuroscience

Lieber Institute awarded $1 million grant to foster racial diversity across neuroscience

Artificial BBB model can help determine how well antibody-based therapies can enter the brain

Artificial BBB model can help determine how well antibody-based therapies can enter the brain

Scientists discover two ways to preserve diseased upper motor neurons in ALS

Scientists discover two ways to preserve diseased upper motor neurons in ALS

Mount Sinai researchers illuminate the role of DNA methylation in Alzheimer's disease

Mount Sinai researchers illuminate the role of DNA methylation in Alzheimer's disease

ApoE4 from neurons plays a critical role in  Alzheimer's disease

ApoE4 from neurons plays a critical role in Alzheimer's disease

"Poisoned" form of a protein could set off events that encourage cancer growth

"Poisoned" form of a protein could set off events that encourage cancer growth

Study: Platelets likely to perform a protective function in AD

Study: Platelets likely to perform a protective function in AD

U.S. people show interest in using genetic technologies to improve offspring education

U.S. people show interest in using genetic technologies to improve offspring education

Researchers establish and characterize a stable iPSC line for modeling human disease

Researchers establish and characterize a stable iPSC line for modeling human disease

Exploring how smoking cannabis alters the oral microbiome and its impact on the brain

Exploring how smoking cannabis alters the oral microbiome and its impact on the brain

New technologies reveal cross-cutting breakdowns in Alzheimer’s disease

New technologies reveal cross-cutting breakdowns in Alzheimer’s disease

UCLA researchers receive NIH award to develop next-generation versions of miniature microscope

UCLA researchers receive NIH award to develop next-generation versions of miniature microscope

New method can identify the vast number of molecules derived from food

New method can identify the vast number of molecules derived from food

Positive social interactions associated with purposefulness in older adults

Positive social interactions associated with purposefulness in older adults

New biomedical research tool may help advance molecular diagnostics and drug discovery

New biomedical research tool may help advance molecular diagnostics and drug discovery

Understanding the regulation of intramembrane proteases across the tree of life

Understanding the regulation of intramembrane proteases across the tree of life

Researchers shed light on development and treatment of brain diseases

Researchers shed light on development and treatment of brain diseases

Researchers analyze single-cell DNA sequencing for having a significant role in Alzheimer’s disease

Researchers analyze single-cell DNA sequencing for having a significant role in Alzheimer’s disease

Mice study explains why humans expressing CHT gene variant exhibit attentional vulnerabilities

Mice study explains why humans expressing CHT gene variant exhibit attentional vulnerabilities

New technique helps rewind the cellular biological clock by around 30 years

New technique helps rewind the cellular biological clock by around 30 years

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.